Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Sarcoma 19 Neoplasms 7 Osteosarcoma 5 Gastrointestinal Stromal Tumors 4 Neuroblastoma 3 Melanoma 3 Uterine Cervical Neoplasms 2 Testicular Neoplasms 2 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Lung Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Desmoid Tumors 2 Colonic Neoplasms 2 Carcinoma, Renal Cell 2 Breast Neoplasms 2 Brain Neoplasms 2 Wilms Tumor 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Somatostatinoma 1 Skin Neoplasms 1 Sarcoma, Myeloid 1 Sarcoma, Ewing 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplastic Cells, Circulating 1

Interventions

Doxorubicin 25 Gemcitabine 16 Trabectedin 12 Ifosfamide 12 Radiotherapy 11 Docetaxel 10 Dacarbazine 8 pazopanib 7 Nivolumab 6 Specimen Handling 5 Biopsy 5 liposomal doxorubicin 4 Temozolomide 4 pembrolizumab 3 Sunitinib 3 Sorafenib 3 Radiation 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 rucaparib 2 pegfilgrastim 2 olaratumab 2 eribulin 2 durvalumab 2 cixutumumab 2 cemiplimab 2 brostallicin 2 belinostat 2 avelumab 2 X-Rays 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Leiomyosarcoma × Blood Specimen Collection × Sarcoma × Clear all

NCT04925089 2026-02-17

Localized Leiomyosarcoma Biomarker Protocol

University of Michigan Rogel Cancer Center

Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡